# LISDEXAMFETAMINE DIMESYLATE
> **ANDA202830** · Abbreviated New Drug Application (Generic) · Sponsor: AMNEAL · Approved 2023-08-25
## Drug
- **FDA Application Number:** ANDA202830
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LISDEXAMFETAMINE DIMESYLATE
- **Generic name:** LISDEXAMFETAMINE
- **Active ingredients:** LISDEXAMFETAMINE DIMESYLATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AMNEAL
- **Manufacturer:** Amneal Pharmaceuticals LLC
- **First approval:** 2023-08-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202830)
---
*AI Analytics · CC0 1.0*